Erik S.G. Stroes

71.0k citations

496 papers · 29.5k indexed · 14 hit papers · h-index 93

Impact in

Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cardiology and Cardiovascular Medicine top 0.1%
- Lipid metabolism and disorders

Papers in

Endocrinology, Diabetes and Metabolism 126
- Diabetes, Cardiovascular Risks, and Lipoproteins 101
Cardiology and Cardiovascular Medicine 161
- Lipid metabolism and disorders 59
- Cardiovascular Health and Disease Prevention 34

Co-authors: John J.P. Kastelein Ton J. Rabelink Max Nieuwdorp S. Matthijs Boekholdt Hans Vink Sotirios Tsimikas Barbara A. Hutten Nicholas J. Wareham
Journals: Atherosclerosis (64 papers)Journal of the American College of Cardiology (28 papers)Arteriosclerosis Thrombosis and Vascular Biology (25 papers)European Heart Journal (24 papers)Current Opinion in Lipidology (21 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Erik S.G. Stroes

488 papers receiving 28.8k citations

Hit Papers

14 papers align trajectories log scale

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels 2022 · 209 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 JAMA
2022 Journal of the American College of Cardiology
2020 New England Journal of Medicine
2020 New England Journal of Medicine
2019 Circulation
2019 New England Journal of Medicine
2019 JAMA
2019 Journal of the American Heart Association
2019 Journal of the American College of Cardiology
2016 The Lancet
2016 JAMA
2016 Circulation
2015 New England Journal of Medicine
2014 Journal of the American College of Cardiology

Peers

Countries citing papers authored by Erik S.G. Stroes

Since Specialization

Citations

This map shows the geographic impact of Erik S.G. Stroes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik S.G. Stroes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik S.G. Stroes more than expected).

Fields of papers citing papers by Erik S.G. Stroes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik S.G. Stroes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik S.G. Stroes. The network helps show where Erik S.G. Stroes may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik S.G. Stroes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik S.G. Stroes Line = papers co-authored together Erik S.G. Stroes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenges in achieving LDL cholesterol targets and novel approaches to lipid lowering European Journal of Preventive Cardiology ·Waqas Malick, Daein Choi, Anne Langsted, Vera Bittner, Børge G. Nordestgaard, Erik S.G. Stroes, Robert S. Rosenson	2025	2
2	Breaking the chains of lipoprotein lipase deficiency: A pediatric perspective on the efficacy and safety of Volanesorsen Molecular Genetics and Metabolism ·A.Y.X Lim, Marion M. Brands, Ilse J.M. Nijhuis, B. Pearce, Sri Hoening Endah Cahyawati, G.H. Hofsteenge, Bart G.P. Koot, Zahra Aeeni, Laura A. Tseng, Erik S.G. Stroes, Peter M. van de Ven, Albert Wiegman, Clara van Karnebeek	2024	2
3	Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia European Journal of Preventive Cardiology ·Popandopulo Ksenia Dmitrievna, Laurens F. Reeskamp, 宋泽斌, G. Kees Hovingh, R. Nils Planken, Willem A. Bax, James K. Min, James P. Earls, Paul Knaapen, Albert Wiegman, Erik S.G. Stroes, Nick S. Nurmohamed	2024	11
4	Diagnostic Accuracy In Coronary CT Angiography Analysis: Artificial Intelligence Versus Visual Assessment Journal of cardiovascular computed tomography ·J. L. Doob, Joice Aparecida Moreira da Silva, Michiel J. Bom, Ruurt Jukema, Robbert de Winter, Ralf W. Sprengers, Erik S.G. Stroes, James K. Min, Laura Asmussen, Ibrahim Danad, Andrew D. Choi, Paul Knaapen	2024	2
5	Tryptophan metabolites and incident cardiovascular disease: The EPIC-Norfolk prospective population study Atherosclerosis ·Ravshanjon Ismoilov, Erik S.G. Stroes, S. Matthijs Boekholdt, Nicholas J. Wareham, Andrew Murphy, Max Nieuwdorp, Stanley L. Hazen, Nordin M.J. Hanssen	2023	24
6	Lifetime exposure to high LDL cholesterol in familial hypercholesterolemia causes coronary atherosclerosis in young adults: The cheetah trial Atherosclerosis ·Dieter Muhs, Weslei de Oliveira Santana, Laurens F. Reeskamp, R. Nils Planken, Rosegen Sarsalejos, James K. Min, James P. Earls, Paul Knaapen, Albert Wiegman, Erik S.G. Stroes, Joice Aparecida Moreira da Silva	2023	1
7	Severe Dyslipidemia Mimicking Familial Hypercholesterolemia Induced by High-Fat, Low-Carbohydrate Diets: A Critical Review Nutrients ·Alexander Sayaverde Osorio, Aldo Grefhorst, Danny M. Cohn, J.H.M. Levels, Jeanine E. Roeters van Lennep, Erik S.G. Stroes, Albert K. Groen, Tycho R. Tromp	2023	16
8	Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction European Heart Journal ·Nick S. Nurmohamed, Jordan M Kraaijenhof, Manuel Mayr, Stephen J. Nicholls, Wolfgang Köenig, Alberico L. Catapano, Erik S.G. Stroes	2023	69
9	Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial Hypercholesterolemia JACC Advances ·Laurens F. Reeskamp, Injeong Shim, Jacqueline S. Dron, Popandopulo Ksenia Dmitrievna, Tycho R. Tromp, Akl C. Fahed, Aniruddh P. Patel, Barbara A. Hutten, Erik S.G. Stroes, G. Kees Hovingh, Amit V. Khera	2023	7
10	Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia Circulation Genomic and Precision Medicine ·Popandopulo Ksenia Dmitrievna, Jeroen van Rooij, Annemieke J.M.H. Verkerk, Sebastian Fries, Linda Zuurbier, Joep C. Defesche, Jorge Peter, Oscar Armenta Estrela, Bahareh Sedaghati-khayat, G. Kees Hovingh, André G. Uitterlinden, Erik S.G. Stroes, Laurens F. Reeskamp	2023	3
11	Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study BMJ Open ·Didier Collard, Nick S. Nurmohamed, Yannick Kaiser, Laurens F. Reeskamp, Tom Dormans, Hazra S. Moeniralam, Suat Şimşek, Renée Douma, M. S. Klamkin, Auke C. Reidinga, Paul Elbers, Martijn Beudel, Liffert Vogt, Erik S.G. Stroes, Bert‐Jan H. van den Born	2021	28
12	Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation Atherosclerosis ·Laurens F. Reeskamp, Tycho R. Tromp, Roeland Huijgen, Erik S.G. Stroes, G. Kees Hovingh, Aldo Grefhorst	2020	8
13	Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment European Heart Journal ·Lotte C.A. Stiekema, Erik S.G. Stroes, Simone L. Verweij, Helina Kassahun, Lisa Chen, Scott M. Wasserman, Marc S. Sabatine, Venkatesh Mani, Zahi A. Fayad	2018	100
14	Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques PLoS ONE ·Sophie J. Bernelot Moens, Sander I. van Leuven, Kang H. Zheng, Stefan R. Havik, Miranda Versloot, Leonie M. van Duivenvoorde, Michael Hahne, Erik S.G. Stroes, Dominique Baeten, Anouk A.J. Hamers	2016	10
15	Intestinal cholesterol secretion: future clinical implications. PubMed ·Lily Jakulj, Joost Besseling, Erik S.G. Stroes, Albert K. Groen	2013	11
16	Abstract 9601: A Statin-Loaded Nanotherapy Increases Anti-Inflammatory Effects of Statin on Atherosclerosis Circulation ·安明霞, Raphaël Duivenvoorden, David Izquierdo‐Garcia, David P. Cormode, Erik S.G. Stroes, Mark E. Lobatto, Emma L. Kuan, Hattori Syun, Valentı́n Fuster, Edward A. Fisher, Willem J. M. Mulder	2011	2
17	AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells Blood ·Federico Mingozzi, J. J. M. Meulenberg, Daniel J. Hui, Etiena Basner‐Tschakarjan, Nicole C. Hasbrouck, Shyrie Edmonson, Natalie A. Hutnick, Michael R. Betts, John J.P. Kastelein, Erik S.G. Stroes, Katherine A. High	2009	227
18	Intramuscular Administration of AAV1-Lipoprotein Lipase ^S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients Arteriosclerosis Thrombosis and Vascular Biology ·Erik S.G. Stroes, Melchior C. Nierman, J. J. M. Meulenberg, Remco Franssen, Jaap Twisk, C. P. Henny, Mario Maas, Aeilko H. Zwinderman, Colin J.D. Ross, Eleonora Aronica, Katherine A. High, Marcel M. Levi, Michael R. Hayden, John J.P. Kastelein, Jan Albert Kuivenhoven	2008	145
19	In Vivo Cell Seeding With Anti-CD34 Antibodies Successfully Accelerates Endothelialization but Stimulates Intimal Hyperplasia in Porcine Arteriovenous Expanded Polytetrafluoroethylene Grafts Circulation ·Joris I. Rotmans, Jan M.M. Heyligers, Hence J.M. Verhagen, Evelyn Velema, J. Ufer, Dominique P.V. de Kleijn, Flip G. de Groot, Erik S.G. Stroes, Gerard Pasterkamp	2005	226
20	Sirolimus-Eluting Stents to Abolish Intimal Hyperplasia and Improve Flow in Porcine Arteriovenous Grafts Circulation ·Joris I. Rotmans, Peter M. T. Pattynama, Hence J.M. Verhagen, Ijai Pereira do Nascimento, Evelyn Velema, Gerard Pasterkamp, Erik S.G. Stroes	2005	58

About Erik S.G. Stroes

Erik S.G. Stroes is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Cancer Research and Immunology, having authored 496 papers that have together received 29.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (207 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (101 papers), Atherosclerosis and Cardiovascular Diseases (70 papers), Lipid metabolism and disorders (59 papers), Cancer, Lipids, and Metabolism (58 papers), Cardiovascular Health and Disease Prevention (34 papers), Adipokines, Inflammation, and Metabolic Diseases (34 papers) and Cholesterol and Lipid Metabolism (31 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.8k citations), Cardiology and Cardiovascular Medicine (8.2k citations), Surgery (13.9k citations), Cancer Research (3.5k citations) and Immunology (3.9k citations). Erik S.G. Stroes has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include John J.P. Kastelein, Ton J. Rabelink, Max Nieuwdorp, S. Matthijs Boekholdt, Hans Vink, Sotirios Tsimikas, Barbara A. Hutten, Nicholas J. Wareham, Kay‐Tee Khaw and Jan Albert Kuivenhoven. Their work appears in journals such as Atherosclerosis, Journal of the American College of Cardiology, Arteriosclerosis Thrombosis and Vascular Biology, European Heart Journal and Current Opinion in Lipidology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact